BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23645838)

  • 1. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.
    Bakchoul T; Greinacher A; Sachs UJ; Krautwurst A; Renz H; Harb H; Bein G; Newman PJ; Santoso S
    Blood; 2013 Jul; 122(3):321-7. PubMed ID: 23645838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.
    Bakchoul T; Boylan B; Sachs UJ; Bein G; Ruan C; Santoso S; Newman PJ
    Transfusion; 2009 Feb; 49(2):265-70. PubMed ID: 19000229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.
    Bakchoul T; Kubiak S; Krautwurst A; Roderfeld M; Siebert HC; Bein G; Sachs UJ; Santoso S
    Transfusion; 2011 Nov; 51(11):2455-61. PubMed ID: 21564107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody.
    Mørtberg TV; Zhi H; Vidarsson G; Foss S; Lissenberg-Thunnissen S; Wuhrer M; Michaelsen TE; Skogen B; Stuge TB; Andersen JT; Newman PJ; Ahlen MT
    Immunohorizons; 2022 Jan; 6(1):90-103. PubMed ID: 35074850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia.
    Bakchoul T; Bertrand G; Krautwurst A; Kroll H; Bein G; Sachs UJ; Santoso S; Kaplan C
    Transfusion; 2013 Sep; 53(9):2078-85. PubMed ID: 23278334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy.
    Eksteen M; Tiller H; Averina M; Heide G; Kjaer M; Ghevaert C; Michaelsen TE; Ihle Ø; Husebekk A; Skogen B; Stuge TB
    J Immunol; 2015 Jun; 194(12):5751-60. PubMed ID: 25972474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.
    Wihadmadyatami H; Heidinger K; Röder L; Werth S; Giptner A; Hackstein H; Knorr M; Bein G; Sachs UJ; Santoso S
    Transfusion; 2015 Dec; 55(12):2920-9. PubMed ID: 26388194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads.
    Chong W; Metcalfe P; Mushens R; Lucas G; Ouwehand WH; Navarrete CV
    Transfusion; 2011 Jun; 51(6):1261-70. PubMed ID: 21166681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa).
    Allen DL; Abrahamsson S; Murphy MF; Roberts DJ
    J Immunol Methods; 2012 Jan; 375(1-2):166-75. PubMed ID: 22036924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.
    Jackson DJ; Eastlake JL; Kumpel BM
    Clin Exp Immunol; 2014 Apr; 176(1):23-36. PubMed ID: 24261689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.
    Socher I; Andrei-Selmer C; Bein G; Kroll H; Santoso S
    Transfusion; 2009 May; 49(5):943-52. PubMed ID: 19175553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: Reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets.
    Refsum E; Meinke S; Gryfelt G; Wikman A; Höglund P
    Thromb Res; 2018 Feb; 162():69-76. PubMed ID: 29306729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A platelet cover-up.
    Arnold DM
    Blood; 2013 Jul; 122(3):307-9. PubMed ID: 23869075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy.
    Kumpel BM; Sibley K; Jackson DJ; White G; Soothill PW
    Transfusion; 2008 Oct; 48(10):2077-86. PubMed ID: 18673340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia.
    Sonneveld ME; Natunen S; Sainio S; Koeleman CA; Holst S; Dekkers G; Koelewijn J; Partanen J; van der Schoot CE; Wuhrer M; Vidarsson G
    Br J Haematol; 2016 Jul; 174(2):310-20. PubMed ID: 27017954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy.
    Kapur R; Kustiawan I; Vestrheim A; Koeleman CA; Visser R; Einarsdottir HK; Porcelijn L; Jackson D; Kumpel B; Deelder AM; Blank D; Skogen B; Killie MK; Michaelsen TE; de Haas M; Rispens T; van der Schoot CE; Wuhrer M; Vidarsson G
    Blood; 2014 Jan; 123(4):471-80. PubMed ID: 24243971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technology.
    Thibaut J; Mérieux Y; Rigal D; Gillet G
    Haematologica; 2012 May; 97(5):696-704. PubMed ID: 22133781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.